TIDMNSCI

RNS Number : 2799C

NetScientific PLC

27 June 2016

("NetScientific" or the "Company" or the "Group")

Grant of Options to Director

London, UK - 27(th) June 2016 - NetScientific plc ("NetScientific", AIM: NSCI), the transatlantic biomedical and healthcare technology group, today announced that on 24(th) June 2016, options over ordinary shares of 5p each were granted to Ian Postlethwaite and Stephen Smith as detailed below.

Ian Postlethwaite joined the Company on the 13(th) June 2016 as Chief Financial Officer, joining the Board immediately following the Company's Annual General Meeting on 15(th) June 2016. Stephen Smith joined the Company on 17(th) of February 2016 as a Non-Executive Director.

 
 Director                Number of Options   Number of Options 
                                   Granted                Held 
--------------------  --------------------  ------------------ 
 Ian Postlethwhaite                180,000             180,000 
 Stephen Smith                      30,000              30,000 
--------------------  --------------------  ------------------

The options have an exercise price of 79.70 pence per share, being the average closing price for the ordinary shares over the five dealing days prior to the date on which the options were granted. The options granted to Ian Postlethwaite and Stephen Smith vest on 13(th) June 2019 and 17(th) February 2019 respectively, being three years from the dates they joined the Company.

- Ends -

For more information, please contact:

 
 NetScientific                            Tel: +44 (0)20 3514 1800 
  François R. Martelet, 
  M.D., CEO 
  Ian Postlethwaite, CFO 
 Investec (NOMAD and                      Tel: +44 (0)20 7597 4000 
  broker) 
  Gary Clarence / Daniel 
  Adams 
  Consilium Strategic                     Tel: +44 (0)20 3709 5700 
   Communications                netscientific@consilium-comms.com 
   Mary-Jane Elliott / 
   Chris Gardner / Jessica 
   Hodgson / Chris Welsh 
   / Laura Thornton

About NetScientific Plc

NetScientific is a biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people's lives and society through improved diagnosis, prognosis and treatment. For more information, please visit the website at www.netscientific.net.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHFQLLLQQFEBBE

(END) Dow Jones Newswires

June 27, 2016 02:00 ET (06:00 GMT)

Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024 Click aqui para mais gráficos Netscientific.
Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024 Click aqui para mais gráficos Netscientific.